Effectiveness and feasibility of transradial approaches for primary percutaneous coronary intervention in patients with acute myocardial infarction

Journal of Nanjing Medical University

Volumn 23, Issue 4, 2009, Pages 270-274

  Gan, Lijun ^a,b   Lib, Qingxian ^b   Liuc, Rong ^c   Zhaoc, Yuxin ^c   Qiuc, Jianjun ^c   Liao, Yuhua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

^c Nongqishi Hospital   (China)

Author keywords

acute myocardial infarction; primary percutaneous coronary intervention; transradial approach

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE HEART INFARCTION; ADULT; ARTERIOVENOUS FISTULA; ARTERY PUNCTURE; ARTICLE; BLEEDING; CANNULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FALSE ANEURYSM; FEASIBILITY STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART DISEASE; HEMATOMA; HOSPITALIZATION; HUMAN; INCIDENCE; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARACENTESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; VASCULAR DISEASE;

EID: 71649115887     PISSN: 10074376     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1007-4376(09)60068-X     Document Type: Article

References (15)

1. Madssen E., Haere P., and Wiseth R. Radial artery diameter and vasodilatory properties after transradial coronary angiography. Ann Thorac Surg 2 (2006) 1698-1702
2. Fu X.H., Hao Q.Q., Jia X.W., Fan W.Z., Gu X.S., Geng W., et al. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Chin Med J (Engl) 121 6 (2008) 522-527
3. Eichhofer J., Horlick E., Ivanov J., Seidelin P.H., Ross J.R., Ing D., et al. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: A large single-center experience. Am Heart J 156 5 (2008) 3435-3439
4. Cruden N.L., Teh C.H., Starkey I.R., and Newby D.E. Reduced vascular complications and length of stay with transradial rescue angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 70 5 (2007) 670-675
5. Ziakas A., Gomma A., McDonald J., Klinke P., and Hilton D. A comparison of the radial and the femoral approaches in primary or rescue percutaneous coronary intervention for acute myocardial infarction in the elderly. Acute Card Care 9 2 (2007) 93-96
6. Lo T.S., Hall I.R., Jaumdally R., Davison P.M., Dickinson K., Hildick-Smith D.J., et al. Transradial rescue angioplasty for failed thrombolysis in acute myocardial infarction: reperfusion with reduced vascular risk. Heart 92 (2006) 1153-1154
7. Kim S.H., Kim E.J., Cheon W.S., Kim M.K., Park W.J., Cho G.Y., et al. Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography. Int J Cardiol 120 3 (2007) 325-330
8. Brasselet C., Tassan S., Nazeyrollas P., Hamon M., and Metz D. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart 93 12 (2007) 1556-1561
9. Sanmartin M., Gomez M., Runoroso J.R., Sadaba M., Martinez M., Baz J.S., et al. Interruption of blood flow during compression and radial artery occlusion after transradial catheterization. Cathet Cardiovasc Interv 70 (2007) 185-189
10. Cantor W.J., Puley G., Natarajan M.K., Dzavik V., Madan M., Fry A., et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction he RADIAL-AMI pilot randomized trial. Am Heart J 150 3 (2005) 543-549
11. Rao S.V., Ou F.-S., Wang T.Y., Roe M.T., Brindis R., Rumsfeld J.S., et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the national cardiovascular data registry(NCDR). JACC Cardiovasc Intervent 1 4 (2008) 379-386
12. Dirksen M.T., Ronner E., Laarman G.J., van Heerebeek L., Slagboom T., van der Wieken L.R., et al. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT. Trial. J Invasive Cardiol 17 10 (2005) 512-517
13. Yan Z.X., Zhou Y.J., Zhao Y.X., Liu Y.Y., Shi D.M., Guo Y.H., et al. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction. Chin Med J (Engl) 121 9 (2008) 782-786
14. Kiemeneij F. Commentary: Cost-effectiveness of transradial coronary access. J Invas Cardiol 19 8 (2007) 354 54
15. Pancholy S., Coppola J., Patel T., and Thomas M. Prevention of radial artery occlusion: Patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Intervent 72 3 (2008) 335-340